Previous 10 | Next 10 |
Shares of Accolade Inc ( NASDAQ: ACCD ) opened about 25% up on Tuesday after the software and technology company reported better-than-expected financial results for its third quarter last night. Q3 results Accolade said its net income printed at $22.5 million in Q3 that tran...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, investor! Grab a cup of coffee and get ready for another busy day of trading as we start with the biggest pre-market stock movers for Tuesday! Source: Shutterstock News moving stocks today include earn...
Image source: The Motley Fool. Accolade, Inc. (NASDAQ: ACCD) Q3 2022 Earnings Call Jan 10, 2022 , 4:30 p.m. ET Operator Continue reading For further details see: Accolade, Inc. (ACCD) Q3 2022 Earnings Call Transcript
Fiscal third quarter 2022 revenue of $83.5 million, a 117% increase compared to fiscal third quarter 2021 revenue of $38.4 million Company introduces preliminary guidance for fiscal year 2023, expecting 25% growth in revenue and a reduction in Adjusted EBITDA loss I...
Accolade went public in July 2020, raising $220 million in a U.S. IPO. The firm provides a healthcare information platform for enterprises and end users. ACCD has grown topline revenue sharply but is producing high and increasing operating losses, so my outlook is Neutral on the s...
SEATTLE, Dec. 16, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), the company reinventing healthcare by helping people live their healthiest lives, today announced that it will release fiscal third quarter 2022 financial results on Monday, January 10, 2022, after the market clo...
Palm Beach, FL – December 13, 2021 – FinancialNewsMedia.com News Commentary – The cloud computing market in the healthcare sector was growing on its own but it has gotten an even bigger boost from the COVID-19 pandemic. Cloud computing has is the practice of...
Credit Suisse drops its best of the best picks to seven stocks for December. Credit Suisse Product Manager Andrew St. Pierre defines the "Top of the Crop" stocks as the "highest conviction combined with the least demanding market expectations. And four new names make that list. The "Top of th...
SEATTLE, Nov. 29, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), a healthcare provider that serves over 400 employers and millions of members, will participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference. A presentation is available for registered attendees via t...
Accolade expands world-class executive leadership team with marketing and customer success experts Accolade welcomes chief marketing officer Carolina Lobo and chief customer officer Eve Stacey to the Personalized Healthcare company's C-suite. PR Newswire SEATTLE ...
News, Short Squeeze, Breakout and More Instantly...
NEW YORK, NY / ACCESSWIRE / July 21, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Accolade, Inc. ("Accolade" or "the Company") (NASDAQ:ACCD). Investors who purchased Accolade securities are encouraged to obtain additional information ...
NEW YORK, NY / ACCESSWIRE / July 15, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Accolade, Inc. ("Accolade" or "the Company") (NASDAQ:ACCD). Investors who purchased Accolade securities are encouraged to obtain additional information ...
NEW YORK, NY / ACCESSWIRE / July 11, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Accolade, Inc. ("Accolade" or "the Company") (NASDAQ:ACCD). Investors who purchased Accolade securities are encouraged to obtain additional information ...